Independent French pharma major Servier announced that the UK’s National Institute for Health and Care Excellence (NICE) has ...

In a dramatic move, the USA has announced a 100% tariff on all patented pharmaceutical imports, a decision aimed at ...

India has moved ahead in developing indigenous capacity for cell and gene therapies, with regulatory bodies issuing national ...

Sino-American antibody company Adagene announced three separate updates on its activities at once on Thursday.

Merck & Co’s Keytruda (pembrolizumab)—in combination with paclitaxel, with or without bevacizumab—has been approved in the ...

US biotech Nanoscope Therapeutics (Nasdaq: NSCI) has appointed Paul Hallen as chief operating officer, adding commercial and ...

US pharma major Eli Lilly (NYSE: LLY) has secured US regulator clearance for Foundayo (orforglipron), a once-daily oral GLP-1 ...

Germany-based newly launched biotech venture builder, BSM Biotech Holdings, today announced that it has formally commenced ...

Positive high-level results have been shared from the EMERALD-3 Phase III trial by AstraZeneca.

Nearly 8,000 clinical trial sites have been disrupted by the USA's escalating war on Iran, according to new analysis from ...

US biotechnology company PranaX has appointed Richard LeConey as chief medical officer, as it looks to strengthen clinical ...

The US Centers for Medicare & Medicaid Services (CMS), through the CMS Innovation Center, announced that organizations ...